Ampliphi Biosciences Corp (NYSEAMERICAN:APHB) was the target of a significant decline in short interest in the month of November. As of November 15th, there was short interest totalling 1,115,468 shares, a decline of 14.8% from the October 31st total of 1,308,517 shares. Approximately 13.0% of the shares of the company are short sold. Based on an average trading volume of 247,174 shares, the days-to-cover ratio is presently 4.5 days.

Shares of Ampliphi Biosciences (APHB) opened at $1.03 on Friday. Ampliphi Biosciences has a fifty-two week low of $0.67 and a fifty-two week high of $6.80.

Separately, HC Wainwright set a $5.00 price target on shares of Ampliphi Biosciences and gave the company a “buy” rating in a report on Monday, October 2nd.

TRADEMARK VIOLATION WARNING: “Ampliphi Biosciences Corp (APHB) Short Interest Down 14.8% in November” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another site, it was illegally copied and reposted in violation of United States & international copyright laws. The original version of this report can be viewed at https://www.thecerbatgem.com/2017/12/02/ampliphi-biosciences-corp-aphb-short-interest-down-14-8-in-november.html.

Ampliphi Biosciences Company Profile

AmpliPhi Biosciences Corporation is a biotechnology company. The Company is focused on the discovery, development and commercialization of phage therapeutics. The Company is engaged in identifying, characterizing and developing naturally occurring bacteriophages with its collaboration partners in bacteriophage biology, synthetic biology and manufacturing, to develop second-generation bacteriophage products.

Receive News & Stock Ratings for Ampliphi Biosciences Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences Corp and related stocks with our FREE daily email newsletter.